Welcome to the ValueWiki Cell Therapeutics, Inc. (CTIC) article! Register for free or click the "edit" link to contribute!

Cell Therapeutics, Inc. (CTIC)

This summary section needs content! Click Here to begin writing.

Have a question about Cell Therapeutics, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

12/02/08 7:12 am	FDA speeds up review of Cell Therapeutics drug (at bizjournals.com)
12/01/08 7:12 am	Cell Therapeutics gets FDA priority review on drug (AP)
12/01/08 7:12 am	Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009 (Business Wire)
12/01/08 1:12 am	Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides (PR Newswire)
12/01/08 1:12 am	FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review (PR Newswire)
11/29/08 11:11 am	Cell Therapeutics, Spectrum in deal to sell Zevalin (at bizjournals.com)
11/28/08 4:11 pm	CELL THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Finan (EDGAR Online)
11/28/08 1:11 am	Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals (PR Newswire)
11/26/08 2:11 pm	Spectrum and Cell Therapeutics to market Zevalin (AP)
11/26/08 10:11 am	Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug (PR Newswire)